Why the study?
Does three-dimensional endocardial impedance mapping accurately delineate the location, size, and border of myocardial infarction in a canine model?
Does three-dimensional endocardial impedance mapping accurately delineate the location, size, and border of myocardial infarction in a canine model?
Three-dimensional endocardial impedance mapping accurately delineates the location, size, and borders of myocardial infarction in a canine model, suggesting potential clinical utility for differentiating healthy from necrotic tissue.
Answers are grounded in this paper and cite their sources.
Impedance mapping feasible for canine infarct delineation; leaves open human validation before clinical adoption.
Precise identification of infarcted myocardial tissue is of importance in diagnostic and interventional cardiology. A three-dimensional, catheter-based endocardial electromechanical mapping technique was used to assess the ability of local endocardial impedance in delineating the exact location, size, and border of canine myocardial infarction. Electromechanical mapping of the left ventricle was performed in a control group (n = 10) and 4 wk after left anterior descending coronary artery ligation (n = 10). Impedance, bipolar electrogram amplitude, and endocardial local shortening (LS) were quantified. The infarcted area was compared with the corresponding regions in controls, revealing a significant reduction in impedance values [infarcted vs. controls: 168.8 +/- 11. 7 and 240.7 +/- 22.3 Omega, respectively (means +/- SE), P < 0.05] bipolar electrogram amplitude (1.8 +/- 0.2 mV, 4.4 +/- 0.7 mV, P < 0. 05), and LS (-2.36 +/- 1.6%, 11.9 +/- 0.9%, P < 0.05). The accuracy of the impedance maps in delineating the location and extent of the infarcted region was demonstrated by the high correlation with the infarct area (Pearson's correlation coefficient = 0.942) and the accurate identification of the infarct borders in pathology. By accurately defining myocardial infarction and its borders, endocardial impedance mapping may become a clinically useful tool in differentiating healthy from necrotic myocardial tissue.
No takes yet. Share an insight, caveat, or question.
Wolf et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: